Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05903911
Other study ID # 2023-0644: RCT
Secondary ID UW Baldwin Endow
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 2024
Est. completion date March 2025

Study information

Verified date May 2024
Source University of Wisconsin, Madison
Contact Louis Lindley, MA
Phone 972-922-5786
Email llindley2@wisc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria. The Trans Care intervention will involve the creation of an online intervention comprised of eight modules intended to reduce symptoms of gender dysphoria, increase active coping, and improve the well-being of TNB individuals. Aim 2 is a randomized controlled trial of the proposed intervention and will enroll 260 TNB participants.


Description:

The overall purpose of this project is to create a free intervention that can be disseminated widely throughout TNB communities to improve well-being in an easy, accessible way. Development and execution of the Trans Care intervention involves two primary aims: - Aim 1) Feasibility and acceptability analysis (FAA) [represented by NCT05884307] - Aim 2) A pilot randomized controlled trial (RCT) of Trans Care's efficacy [represented in this study record] Aim 2 is a RCT in which participants' scores of psychological wellbeing and coping strategies in the intervention vs waitlist control group will be analyzed. Additionally, participants who drop out of the RCT will be asked to complete measures at dropout to determine what dose size of Trans Care (i.e., how many modules) is necessary to have a significant change in mental well-being. Finally, waitlisted participants will be offered the intervention within one month of the completion of data collection. Aim 2 Hypotheses: - TNB Participants who received the Trans Care intervention will demonstrate improvement on quantitative measures of psychological well-being, GD symptoms, and coping strategies compared to waitlisted individuals. - Changes will be maintained at 3 months follow-up indicating that the Trans Care intervention has a sustained impact on improving TNB individuals' coping. Aim 2 Endpoints: The primary endpoint of Aim 2 will be to determine if participants who engaged the Trans Care intervention experienced psychological improvement in their mental health as a result of completing the intervention.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 260
Est. completion date March 2025
Est. primary completion date March 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Identify as transgender, transsexual, nonbinary, and/or have a transgender history. - Experience gender dysphoria. - Time available to commit to completing a 4-5-hour online intervention and 1-2 hours to complete follow up surveys Exclusion Criteria: - under 18 years old - individual does not identify as transgender, transsexual, nonbinary, and/or have a transgender history - does not experience gender dysphoria - is unable to commit to the time requirements of the study - does not have access to an internet compatible device

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Trans Care Web App
an educational and interactive website designed to improve coping strategies of TNB individuals

Locations

Country Name City State
United States University of Wisconsin Madison Wisconsin

Sponsors (1)

Lead Sponsor Collaborator
University of Wisconsin, Madison

Country where clinical trial is conducted

United States, 

References & Publications (1)

Lindley, L., & Budge, S. L. (2022). Development and validation of the Trans and Nonbinary Coping Measure (TNCM): A measure of trans and nonbinary specific ways of coping with gender-related stress. Psychology of Sexual Orientation and Gender Diversity. Advance online publication. https://doi.org/10.1037/sgd0000618

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Depression, Anxiety, and Stress Scale (DASS-21) Score DASS-21 is a composite measurement used to assess symptoms of depression, anxiety, and stress in community settings. The 21-item survey is comprised of three subscales for Depression, Anxiety, and Stress. Responses are provided on a 4-point Likert scale, Where 0 = Did not apply to me, 1 = applied to me some degree, or some of the time, 2 = applied to me a considerable degree or good part of time, and 3 = applied to me very much or most of the time. Total possible range of scores is from 0 to 63, with higher scores indicating higher levels of symptoms. before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
Primary Change in Gender Congruence and Life Satisfaction Scale (GCLS) Score GCLS measures gender congruence and life satisfaction in a 38-item self assessment, for a total possible range of scores from 38-190 where higher values indicate greater gender congruence, greater gender-related well-being, and greater life satisfaction. before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
Primary Change in Modified Gender Minority Stress and Resilience measure (M-GMSRM) Score Total scores are calculated for each scale based on summed values assigned to possible response options. The first 8 items are scored 0 for "never," 1 for "yes, before age 18," 2 for "yes, after age 18," and 3 for "yes, in the past year." Scores from these items are then summed where a higher score indicates more frequent and recent experiences of gender related prejudice. All other items are scored from 0 - 4 according to responses ranging from strongly disagree to strongly agree. Items within each subscale (i.e., non-affirmation of identity, internalized transphobia, and negative expectations for the future) are summed with high scores indicating greater distress. before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
Primary Change in Trans and Nonbinary Coping Measure (TNCM) Score TNCM assesses the unique ways of coping with gender-related stress. The measure includes six subscales (Social Support/Connection (5 items); Social Activism (4 items); Hope (5 items); Strategic Gender Expression (5 items); Behavioral Avoidance (5 items); Identity Nondisclosure (4 items). Responses to items are recorded on a 5-point scale from 1 (I do not do this) to 5 (I almost always do this). Scale items are summed to create subscale scores. A higher score indicates greater frequency of use of that coping strategy. before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
Primary Alcohol Use Disorder Identification Test This is scored from 0-4 where higher scores are indicative of increased dependence on alcohol. before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
Primary Number of Days in the Past Week You Consumed Alcohol 7 = 7 days, 6 = 6 days, 5 = 5 days, 4 = 4 days, 3 = 3 days, 2 = 2 days, 1 = 1 day, 0 =no days before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
Primary Quantity of Alcohol Use How many alcoholic drinks, on average, have you had per day during the pastweek? An alcoholic drink is defined as 1 beer, 1 glass of wine, 1 shot of alcohol, or 1mixed drink.
Response options:
5 = 12+ drinks, 4 = 8-11 drinks, 3 = 5-7 drinks, 2 = 3-4 drinks, 1 = 1-2 drinks, 0 =none
before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
See also
  Status Clinical Trial Phase
Recruiting NCT06098781 - Gynaecological Gender-affirming Surgeries
Recruiting NCT04064671 - ZEPHYR: A Study Evaluating Surgical Outcome After Implantation of the Zephyr ZSI 475 FTM Inflatable Penile Implant in the Neophallus After Female-to-male Sex Reassignment Surgery
Completed NCT03602222 - An LGBT-Competency Program for Mental Health Professionals in Romania N/A
Completed NCT04708600 - Effectiveness of Speech Therapy in Trans Women. N/A
Completed NCT04195659 - Chest Dysphoria in Transmasculine Spectrum Adolescents
Not yet recruiting NCT04160364 - Gender Dysphoria in Children and Adolescents : Parents' Perspectives
Not yet recruiting NCT04265885 - Gender Dysphoria and Transition
Recruiting NCT06245681 - Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content
Active, not recruiting NCT05489159 - Sleep and IR in Transgender Adolescents
Recruiting NCT04736797 - Transition in Transgender
Recruiting NCT04979338 - Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries Phase 3
Recruiting NCT05829928 - Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
Recruiting NCT04993469 - Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery N/A
Recruiting NCT05884307 - Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria N/A
Recruiting NCT05883553 - Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients. N/A
Completed NCT04290286 - i2TransHealth: Interdisciplinary, Internet-based Trans Health Care N/A
Terminated NCT03078829 - The Relation of GnRH Treatment to QTc Interval in Transgender Females
Recruiting NCT05649605 - Early Mental Response - The EMRE Study N/A
Recruiting NCT05204732 - Acoustic and Perceptual Effects of Intonation Training in Gender Diverse People N/A
Recruiting NCT06291675 - Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content